Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: BIGFRED who wrote (1858)	10/17/1998 2:35:00 PM
From: DARPA	Read Replies (1) \| Respond to of 4650

Please expand ... I suspect a much bigger pop after the test is done back east in a couple of months. Why more tests? Who is doing the testing back East? What do we hope to accomplish? What's wrong with the LungCheck tests? Why would we need more testing? Lastly, there are other technologies out there that will clean Biomoda's clock unless they can get product and start delivering soon. Here's one technology that could very well render Biomoda's cure arcane, out of date, and unviable. We could still use Biomoda's diagnostics, but the pudding (aka $$) is in the cure. And someone else is well on the way to the cure ... In a nutshell, here is how it works, take this pill and any cancer in your body is killed by cutting off all blood supply to the cancerous cells. It's going into Phase III trials as we speak. Saw a great documentary on it on a Canadian show (W5, I think - Anyone else see it and can remember?) (if you're interested, see NeoVastat at the following web site... pharmacology.tqn.com